Funding for Basic Scientific Research Remains Critical
SfN President Eric Nestler is featured in The Hill highlighting the importance of funding for basic scientific research.
In the op-ed Nestler states, "While corporate research and development is essential, it does not replace the role of federal science investment, but rather complements it. Mergers between major companies have consolidated the industry, reducing the overall investment in novel medications and technologies. In brain research, virtually all companies have pulled back, stating they need precisely what only federally funded basic research produces: new understanding and validated targets."